BEVC, a life-sciences investor, is in the process of raising a $25 million fund specifically geared towards climate-related startups, as indicated by an SEC filing.
Founded just last year, BEVC is a relatively new player in the investment scene. The company’s three co-founders all have extensive backgrounds in the life sciences, with their initial investments focusing on Radar Therapeutics and Insamo within the life sciences field. However, their latest filing suggests a shift towards investing in climate tech startups.
BEVC joins a growing trend of life sciences investors expanding their scope beyond human health to include planetary health. Notably, RA Capital established a planetary health team last year, and Flagship Pioneering recently raised $3.6 billion to support breakthrough innovations in health, sustainability, and AI startups.
The decision to pivot towards climate-related investments stems from the recognition that a healthy environment is essential for overall human health, as stated by RA Capital Planetary Health managing partner Kyle Teamey.
With all three co-founders holding PhDs in life sciences and a blend of operational and investment experience, BEVC is well-positioned to navigate this dual focus. Each co-founder brings unique expertise to the table, with backgrounds from leading organizations such as Johnson and Johnson, GE Ventures, and B Capital Group.
The firm’s panel of advisors further strengthens their foundation, featuring esteemed individuals like Nobel Prize winners Jennifer Doudna and Carolyn Bertozzi, UC-Berkeley’s biosciences institute QB3 executive director David Schaffer, and former president of the Howard Hughes Medical Institute Robert Tjian.
At the time of this report, BEVC has not responded to requests for comments.
